华为 WATCH D3 亮相长城会:AI 加健康赋能心血管慢病管理Huawei WATCH D3 Debuts at Great Wall Conference: AI + Health for Cardiovascular Chronic Disease Management


AI free token/AI免费积分
华为 WATCH D3 亮相长城会:AI 加健康赋能心血管慢病管理

2026 年 10 月 16 日,第 37 届长城心脏病学大会暨亚洲心脏大会 2026 在京举行。华为举办运动健康专题会,分享智能穿戴设备最新研究成果,并邀请心血管病学、高血压防治领域顶尖专家共同探讨前沿医学进展与创新技术应用。

在「华为运动健康专题」会上,长城会理事长、北京大学第三医院副院长唐熠达教授发表《最大摄氧量对心血管风险人群的预测及早期预警价值》主题演讲,披露与华为的课题合作已初步验证以穿戴设备无感估算最大摄氧量的可行性与准确性,并指出「最大摄氧量有望成为数字健康时代的心血管风险预警核心指标」。

中国人民解放军总医院心血管病医学部主任陈韵岱教授在《AI 随访在血压管理中的应用》演讲中提到,基于 20 余万华为穿戴用户数据,睡眠与血压控制存在关联,双方正通过 AI 随访把血压管理延伸到院外。上海交通大学医学院附属瑞金医院高血压科主任王继光教授则介绍了与华为合作的轻触式动态血压监测研究——在减少测量次数的同时保持与标准动态血压监测一致的结果。

大会展区现场,HUAWEI WATCH 6 系列、GT7 系列及 FIT 系列等产品集中展出,其中腕部动态血压记录仪 HUAWEI WATCH D3 吸引众多嘉宾驻足。由上海市高血压研究所与华为合作的轻触式动态血压监测,将气囊测量从全天 27 次以上减少到 7 次;配合更轻薄的气囊表带设计,连续监测不再打扰日常作息。

HUAWEI WATCH D3 把血压管理带进更多日常场景:可随时启动单次测量,也可开启动态血压监测自动记录昼夜变化,运动前后还能获得血压提醒与解读;一键微体检最多可呈现 17 项健康指标。

华为终端 BG 智能穿戴与运动健康产品线副总裁龚元松介绍,据 GfK、IDC 数据,华为穿戴已连续 7 年保持中国穿戴市场份额第一,2026 年上半年其全球份额第一;HUAWEI WATCH D 系列已迭代三代,依托玄玑超感知模组持续优化。目前华为创新研究平台已携手 180 余家机构、开展 340 余项研究,并有 130 余篇论文在权威学术平台发表。

本文来源:https://www.cet.com.cn/itpd/hlw/10618118.shtml
若有版权问题,请来信告知:13951431913#139.com 或在右方提交评论。

On October 16, 2026, the 37th Great Wall Cardiology Conference and Asian Heart Conference 2026 was held in Beijing. Huawei held a sports health conference to share the latest research results of smart wearables, and invited top experts in the fields of cardiovascular medicine and hypertension prevention to discuss cutting-edge medical advances and innovative technology applications.

At the "Huawei Sports Health Special Session", Professor Tang Yida, Chairman of the Great Wall Council and Vice President of the Third Hospital of Peking University, delivered a keynote speech entitled "Prediction and Early Warning Value of Maximum Oxygen Intake for Cardiovascular Risk Populations", disclosing that the project cooperation with Huawei has been preliminarily verified to estimate the feasibility and accuracy of maximum oxygen intake without wearable devices, and pointed out that "maximum oxygen intake is expected to become the core indicator of cardiovascular risk early warning in the digital health era".

Professor Chen Yundai, director of the Cardiovascular Disease Medical Department of the Chinese People's Liberation Army General Hospital, mentioned in his lecture "Application of AI Follow-up in Blood Pressure Management" that based on more than 200,000 Huawei wearable user data, there is a link between sleep and blood pressure control, and the two sides are extending blood pressure management outside the hospital through AI follow-up. Professor Wang Jiguang, director of the Department of Hypertension at Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, introduced the light-touch ambulatory blood pressure monitoring study in cooperation with Huawei - keeping the results consistent with the standard ambulatory blood pressure monitoring while reducing the number of measurements.

The Huawei watch 6 series, GT7 series and fit series were exhibited at the exhibition area, among which the wrist dynamic blood pressure recorder Huawei watch D3 attracted many guests. The light-touch dynamic blood pressure monitoring cooperated by the Shanghai Institute of Hypertension and Huawei has reduced the measurement of airbags from more than 27 times a day to 7 times; with the design of a lighter and thinner airbag strap, continuous monitoring no longer disturbs daily routine.

Huawei WATCH D3 Debuts at Great Wall Conference: AI + Health for Cardiovascular Chronic Disease Management

Huawei watch D3 brings blood pressure management into more everyday scenarios: a single measurement can be started at any time, state blood pressure monitoring can be started to automatically record day and night changes, and blood pressure reminders and interpretations can be obtained before and after exercise; one-click micro-health examination can present up to 17 health indicators.

According to Gong Yuan-song, vice president of Huawei's terminal BG smart wear and sports health product line, according to GfK and IDC data, Huawei wear has maintained China's first wearable market share for seven consecutive years and its first global share in the first half of 2026; Huawei watch D series has been iterated for three generations, relying on the Xuanji ultra-sensitive module for continuous optimization. At present, Huawei's innovation research platform has cooperated with more than 180 institutions, carried out more than 340 studies, and more than 130 papers have been published on authoritative academic platforms.

This article is from: https://www.cet.com.cn/itpd/hlw/10618118.shtml For copyright issues, please write to: 13951431913#139.com or submit a review on the right.

暂无评论,快来发表第一条评论吧!No comments yet. Be the first!

📮 需求咨询📮 Inquiry